Michael Petrany Is the First Whitsett Fellow in the MD/PhD Program
Michael Petrany was exposed to the marriage of research and medicine while still an undergraduate at Xavier University.
Petrany worked in the lab of Burns Blaxall, PhD, at Cincinnati Children's Hospital Medical Center with a team of talented researchers and skilled physicians. The experience influenced him to apply to the UC College of Medicine's Medical Scientist Training Program (MSTP), to earn a joint MD and PhD.
"I think there is a great need for physicians willing to follow this track, explains Petrany. "It's a particular niche that is filled mostly by MD-PhDs in terms of bridging the gap from basic and translational to biomedical research to the bedside.
The 22-year-old Huntington, West Virginia, native is the first recipient of the new Jeffrey A. Whitsett Physician Scientist Training Fellowship, a joint fellowship between the MSTP and the UC Molecular and Developmental Biology graduate program.
The fellowship is named after Jeffrey Whitsett, MD, a world leader in pediatric research, who is a professor in the UC Department of Pediatrics and co-director of the Perinatal Institute and chief of the section of Neonatology, Perinatal and Pulmonary Biology at Cincinnati Childrens.
The unique aspect of this fellowship is that fellows meet with Whitsett on a regular basis to receive professional development counseling and career advice, explains Gurjit Khurana Hershey, MD, PhD, director of the MSTP program at UC.
"The goal of the fellowship is to train physician scientists to become world leaders in research into health and diseases both at the bench and the bedside, says Hershey.
With opportunities to attend medical school across the country, Petrany says the partnership between the College of Medicine and Cincinnati Childrens is what brought him to UC.
"For the latter two years of college, I was doing research at Cincinnati Children's and I was incredibly impressed with the culture, said Petrany. "There was an attitude of collaboration and respect, and I think there is more humility here than at a lot of academic institutions, but it is not to the detriment of rigor and productivity.
As part of the MSTP, Petrany will spend his first two years in medical school and then join a laboratory in the Molecular and Developmental Biology graduate program, says Andrea DeSantis, program manager for the Medical Scientist Training Program.
After completing his PhD, he will return to medical school for his last two years of clinical rotations. Petrany joins eight other students from across the country in the first-year MSTP class who are dedicating the next seven to eight years to train as physician scientists.
The MSTP admits students through a single process into UCs College of Medicine for both medical and graduate training. Currently, 52 students are enrolled and 82 have graduated since the programs inception in 1985.
The Jeffrey A. Whitsett fellowship provides tuition support for seven years and includes a $26,000 annual stipend. Interested applicants are encouraged to contact the program at mstp@uc.edu. More information can be found at: www.med.uc.edu/MSTP
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.